Sulzer aims to take the wear out of joints:
This article was originally published in Clinica
Executive Summary
Swiss company Sulzer Orthopaedics has licensed from the Massachusetts Institute of Technology and Massachusetts General Hospital in the US a new ultra low wear material to improve the performance of replacement joints. The deal gives Sulzer worldwide rights to a polyethylene developed in Massachusetts. The new polyethylene material aims to reduce the incidence of osteolysis, the number one cause of hip implant failure where bone is eroded around the implant. The material will be used to line acetabular inserts, cup like metal implants into which the ball shaped femoral head fits.
You may also be interested in...
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.